Cardio Diagnostics Holdings, Inc.
CDIOW- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $139.7K in total; no superinvestor holds it.
Other share classesCDIO
Q4 2022 vs. Q3 2022
How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 0 | 21 | +21 |
| Shares | 0 | 1.53M | +1.53M |
| Value | $0 | $66.9K | +$66.9K |
New holders (21)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EHP Funds Inc. | 364,492 | $18.0K | 0.00% |
| Saba Capital Management, L.P. | 235,597 | $11.7K | 0.00% |
| Atw Spac Management LLC | 100,000 | $4.95K | 0.00% |
| K2 Principal Fund, L.P. | 92,500 | $4.58K | 0.00% |
| Polar Asset Management Partners Inc. | 89,943 | $4.33K | 0.00% |
| D. E. Shaw & Co., Inc. | 74,822 | $3.70K | 0.00% |
| Yakira Capital Management, Inc. | 69,499 | $3.44K | 0.00% |
| Rivernorth Capital Management, LLC | 49,999 | $2.50K | 0.00% |
| CNH Partners LLC | 46,442 | $2.30K | 0.00% |
| Walleye Capital LLC | 42,915 | $2.12K | 0.00% |
| Shaolin Capital Management LLC | 47,000 | $2.00K | 0.00% |
| Wolverine Asset Management LLC | 29,959 | $1.48K | 0.00% |
| Gabelli Funds LLC | 26,290 | $1.30K | 0.00% |
| Walleye Trading LLC | 24,139 | $1.20K | 0.00% |
| Gabelli & Co Investment Advisers, Inc. | 22,410 | $1.11K | 0.00% |
| HRT Financial LP | 36,200 | $1.00K | 0.00% |
| Susquehanna International Group, LLP | 12,483 | $618 | 0.00% |
| Castle Creek Arbitrage, LLC | 11,710 | $564 | 0.00% |
| UBS Group AG | 52 | $3 | 0.00% |
| Radcliffe Capital Management, L.P. | 50,000 | – | – |
| Boothbay Fund Management, LLC | 100,000 | – | – |
Sold out (0)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
None.